March/April

Going Beyond the Prescription in Specialty Pharmacy

March 15, 2019

Features

A data-centric approach is vital for patients with complex conditions, particularly in determining what has worked well and anticipating what medical or pharmacy care is required for effective outcomes in the future.

Uncovering Hidden Savings in the Hospital Pharmacy

March 15, 2019

Features

The shift from fee-based, volume-driven care to value-based, patient-centered care and the growth of specialty pharmaceuticals are propelling us all into uncharted territory, no matter what role you play in health care.

Understanding and Navigating Specialty and Orphan Drug Challenges in the 340B Program

March 15, 2019

Features

Failure to recognize the interests of manufacturers to ensure proper use of 340B pricing may result in 340B hospitals missing the opportunity to secure and retain discounts on key orphan and specialty drugs or may render them unable to access the drugs at all.

International Drug Pricing Index Model Could Restrict Innovation, Access

March 15, 2019

Features

This proposal, outlined by the Centers for Medicare & Medicaid Services (CMS) in late 2018, would undermine CMS’ stated goal of prioritizing value and improved patient outcomes over utilization and sickness.